Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, HomologousMultiple MyelomaTransplantation ConditioningMelphalanCombined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeRemission InductionSalvage TherapyStem CellsBone Marrow TransplantationDisease-Free SurvivalHodgkin DiseaseLymphoma, Non-HodgkinEtoposideMyeloablative AgonistsRecurrenceHematopoietic Stem Cell MobilizationCarmustineCyclophosphamideCytarabineGraft vs Host DiseaseBone Marrow PurgingSurvival RateVincristineHematologic NeoplasmsLiver TransplantationThiotepaWhole-Body IrradiationGraft SurvivalSurvival AnalysisRetrospective StudiesHematopoietic Stem CellsBusulfanLymphoma, Mantle-CellAmyloidosisAntigens, CD34DexamethasoneBoronic AcidsPyrazinesAntibodies, Monoclonal, Murine-DerivedPrognosisFollow-Up StudiesThalidomideLeukapheresisDoxorubicinAntineoplastic Agents, AlkylatingLymphoma, FollicularAutograftsKidney TransplantationGranulocyte Colony-Stimulating FactorLymphoma, T-Cell, PeripheralMesenchymal Stem Cell TransplantationCell TransplantationPrednisoneTime FactorsTransplantation ChimeraLymphomaTissue DonorsIfosfamideNeoplasm, ResidualPodophyllotoxinCord Blood Stem Cell TransplantationInduction ChemotherapyLeukemia, Myeloid, AcuteLymphoma, Large B-Cell, DiffuseMaintenance ChemotherapyAntineoplastic AgentsMyelodysplastic SyndromesIdarubicinImmunosuppressive AgentsHeart TransplantationBlood Component RemovalEmbryonic Stem CellsEnteropathy-Associated T-Cell LymphomaLymphoma, B-CellLung TransplantationHistocompatibility TestingLeukemia, Plasma CellInfusions, SpinalAdult Stem CellsNeoplasms, Second PrimaryMitoxantroneProspective StudiesFeasibility StudiesCell DifferentiationAntibodies, MonoclonalHematopoiesisTransplantation ImmunologyHistocompatibilityBone MarrowGraft RejectionLeukemiaOrgan TransplantationBlood Transfusion, AutologousLeukemia, Myeloid